An open-label extension study of oral Triheptanoin as an add-on treatment to adolescent and adult participants with medically refractory epilepsy (2014–2016)
- Grant type:
- Ultragenyx Pharmaceutical Inc
- Researchers:
-
-
Associate Professor
School of Biomedical SciencesFaculty of Medicine
-
- Funded by:
- Ultragenyx Pharmaceutical Inc.
